Results 21 to 30 of about 77,233 (255)

Polypharmacy and excessive polypharmacy in community-dwelling middle aged and aged adults between 2011 and 2015 [PDF]

, 2021
AIMS: We aimed to assess the prevalence, components and evolution of polypharmacy and to evaluate risk factors associated with polypharmacy. METHODS: A retrospective dynamic cohort study was performed, using a primary healthcare database comprising ...
van den Akker, Marjan, van den Akker, M., Van Pottelbergh, G., Spriet, Isabel, Vaes, Bert, Hellemans, Laura, Van Pottelbergh, Gijs, Hias, Julie, Rygaert, Xavier, van der Linden, Lorenz, Nuyts, S., Tournoy, Jos, Hellemans, L., Nuyts, Shauni, Rygaert, X., Hias, J., Spriet, I., van der Linden, L., Tournoy, J., Vaes, B., Marjan Akker, Isabel Spriet, Lorenz Van der Linden, Bert Vaes, Laura Hellemans, Jos Tournoy, Shauni Nuyts, Xavier Rygaert, Julie Hias, Gijs Van Pottelbergh   +29 more
core   +1 more source

Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study

BMJ Open, 2016
Objectives (1) To evaluate the prevalence of polypharmacy (5–9 medicines) and excessive polypharmacy (10+ medicines) and (2) to determine associated demographic and clinical characteristics in an ageing population with intellectual disabilities (IDs ...
Mary McCarron, Philip McCallion, Máire O'Dwyer, Jure Peklar, Martin C Henman   +4 more
doaj   +1 more source

Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy - a prospective randomised controlled trial [PDF]

, 2016
In 2010 the 'Polymedication Check' (PMC), a pharmacist-led medication review, was newly introduced to be delivered independently from the prescriber and reimbursed by the Swiss health insurances.
Vriends, Noortje, Kurt E. Hersberger, Eva Blozik, Hersberger, Kurt E., Markus Messerli, Messerli, Markus, Eva Blozik (618302), Noortje Vriends, Blozik, Eva, Kurt Hersberger (3430292), Markus Messerli (3430298), Noortje Vriends (3430295), Hersberger KE, Messerli M, Vriends N, Blozik E   +15 more
core   +1 more source

Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: a retrospective cohort study [PDF]

Intestinal Research, 2019
Background/Aims Polypharmacy is a common clinical problem with chronic diseases that can be associated with adverse patient outcomes. The present study aimed to determine the prevalence and patient-specific characteristics associated with polypharmacy in
Jingzhou Wang, Takahiro I Nakamura, Anne G Tuskey, Brian W Behm   +3 more
doaj   +1 more source

Prevalence and Age Structure of Polypharmacy in Poland: Results of the Analysis of the National Real-World Database of 38 Million Citizens

Frontiers in Pharmacology, 2021
Introduction: Polypharmacy is a risk factor for adverse health outcomes, higher use of medical services and additional costs. The problem has gained attention as a consequence of aging and related multimorbidity.
Przemysław Kardas, Filip Urbański, Aneta Lichwierowicz, Ewa Chudzyńska, Grzegorz Kardas, Marcin Czech   +5 more
doaj   +1 more source

Polypharmacy among community-dwelling elderly in Singapore: Prevalence, risk factors and association with medication non-adherence

Proceedings of Singapore Healthcare, 2019
Background: Polypharmacy, given its link with drug interactions, potentially inappropriate medications and medication non-adherence, may pose a significant health risk, especially among the elderly.
Yi Wen Tan, Sumithra Suppiah, Mary Ann C Bautista, Rahul Malhotra   +3 more
doaj   +1 more source

Polypharmacy and the coproduction of the experience between physicians and patients

Teoria e Prática em Administração, 2021
Purpose: To identify how physicians can help polypharmacy patients deal with their disease condition by focusing on the non-clinical factors of care processes.
Md Mafuzul Huq, Julie Maryne Fingolo, Claudia Araujo   +2 more
doaj   +1 more source

The epidemiology of polypharmacy [PDF]

, 2016
Polypharmacy describes, in simplistic terms, the use of multiple medications in an individual. It has become a normal aspect of modern medicine, driven by an ageing, multimorbid population, the increasing availability of preventative medications and an ...
Payne, Rupert A
core   +1 more source

Is shared decision-making a determinant of polypharmacy in older patients with chronic disease? A cross-sectional study in Hubei Province, China

BMC Geriatrics, 2023
Background Shared decision-making(SDM) is recognized as an important means of managing polypharmacy among older people with chronic diseases. However, no studies have quantitatively measured the effect of SDM on polypharmacy.
Qiao Zong, Zhanchun Feng, Jia Wang, Zehao Zheng, Chaoyi Chen, Da Feng   +5 more
doaj   +1 more source

Polypharmacy in elderly cancer patients : challenges and the way clinical pharmacists can contribute in resource-limited settings [PDF]

, 2019
The aim of this study was to address the problems associated with polypharmacy in elderly cancer patients and to highlight the role of pharmacists in such cases in resource‐limited settings.
Saval Khanal, Khanal, Saval, Shrestha, Sudip, Sudip Shrestha, Khanal, S, Shrestha, S, Shrestha, Sunil, Sunil Shrestha   +7 more
core   +1 more source